TAK
Takeda Pharmaceutical Company Limited
Revenue to net incomeFY2025
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | ¥4.51TFY2026 | +7.1% |
| Gross profit | ¥2.93TFY2026 | +5.9% |
| Operating income | ¥6.2BFY2026 | −58.6% |
| Net income | −¥152.4BFY2026 | — |
| EPS | −¥96.75FY2026 | — |
| Free cash flow | ¥865.4BFY2026 | −0.8% |